Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants

Journal of Structural Biology

Volumn 130, Issue 2-3, 2000, Pages 339-351

  Morozova Roche, Ludmilla A ^a   Zurdo, Jesús ^a   Spencer, Andrew ^a,b   Noppe, Wim ^c   Receveur, Veronique ^a   Archer, David B ^b   Joniau, Marcel ^c   Dobson, Christopher M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Amyloid fibril; Amyloidosis; Folding intermediate; Nucleation; Seeding

Indexed keywords

AMYLOID; LYSOZYME;

AMYLOIDOSIS; ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; ELECTRON MICROSCOPY; HUMAN; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; TEMPERATURE DEPENDENCE;

EID: 0033849915     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.2000.4264     Document Type: Article

References (72)

1. Hen egg white lysozyme expressed and secreted from Aspergillus niger is correctly processed and folded
2. Diffuse intervertebral disk calcification in primary amyloidosis
3. Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin
4. Characterisation of a partially folded protein by NMR methods: Studies of the molten globule state of guinea pig α-lactalbumin
5. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibrils is a continuous β-sheet helix
6. A molecular model of the amyloid fibrils
7. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
8. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene
9. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent
10. Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behaviour in its disease-related variants
11. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation
12. Designing conditions for in vitro formation of amyloid protofilaments and fibrils
13. Protein misfolding, evolution and disease
14. The structure, stability and folding process of amyloid mutant human lysozyme
15. Amyloidosis: A review of recent diagnostic and therapeutic developments
16. +], a heritable prion-like factor of S. cerevisiae
17. Ion distribution in lysosomal suspensions
18. Amyloid fibril formation by an SH3 domain
19. Hydrophobic interaction of lysozyme and α-lactalbumin from equine milk whey
20. 2+ binding site into human lysozyme
21. An equilibrium partially folded state of human lysozyme at low pH
22. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
23. 'Fragile' liver and massive hepatic haemorrhage due to hereditary amyloidosis
24. The same prion strain causes vCJD and BSE
25. The refolding of human lsyozyme: A comparison with the structurally homologous hen lysozyme
26. A role for destabilizing amino acid replacements in light-chain amyloidosis
27. The C-terminus of the β protein is critical in amyloidogenesis
28. Amyloid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB
29. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing
30. Protein secondary structure and circular dichroism: A practical guide
31. The environmental dependency of protein folding best explains prion and amyloid diseases
32. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments
33. Quantitative evaluation of congo red binding to amyloid-like proteins with a β-pleated sheet conformation
34. Two simple methods for quantifying low-affinity dye substrate binding
35. The molten globule state of α-lactlabumin
36. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
37. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: Implication for wild-type, V30M, and L55P amyloid fibril formation
38. Thioflavine-T interaction with synthetic Alzheimers-disease β-amyloid peptides - Detection of amyloid aggregation in solution
39. Thioflavine-T interaction with amyloid β-sheet structures
40. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module
41. Amyloid-associated proteins α-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments
42. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease
43. Lysozyme, a major low-molecular-weight cationic protein of the intervertebral disc, which increases with ageing and degeneration
44. Localization of perlecan (or a perlecanrelated macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of β-amyloid protein into rodent hippocampus
45. Structural basis of the stability of a lysozyme molten globule
46. Structural characterisation and comparison of the native and Astates of equine lysozyme
47. Independent nucleation and heterogenevus assembly of structure during folding of equine lysozyme
48. Simple twostep procedure for the preparation of highly active pure equine milk lysozyme
49. The lysosomal proton pump and its effect on protein breakdown
50. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents
51. Amyloid, familial Mediterranean fever, and acute phase response
52. Human lysozyme gene mutations cause hereditary systemic amyloidosis
53. Amyloid fibrils - Mutations make enzyme polymerize
54. Glutamine repeats and neurodegenerative diseases: Molecular aspects
55. Measurement of lysozyme in human body fluids: Comparison of various enzyme immunoassay techniques and their diagnostic application
56. Molten globule and protein folding
57. On the binding of Congo red by amyloid
58. The folding of hen lysozyme is a complex process involving partially structured intermediates and multiple pathways
59. α-Lactalbumin forms a compact molten globule in the absence of disulfide bonds
60. Modulating conformational factors in transthyretin amyloid
61. Pharmacological aspects and therapeutic applications of lysozymes
62. Study of the 'molten globule' intermediate state in protein folding by a hydrophobic fluorescent probe
63. The concept of a random coil. Residual structure in peptides and denatured proteins
64. Apolipoprotein E and Alzheimer's disease
65. Expression, purification and characterisation of the recombinant calcium-binding equine lysozyme secreted by filamentous fungus Aspergillus niger. Comparison with the production of hen egg white and human lysozymes
66. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites
67. The structure of amyloid fibrils by electron microscopy and X-ray diffraction
68. Amyloidosis
69. Strain-specific prion-protein conformation determined by metal ions
70. Ageing and amyloid fibrillogenesis: Lessons from apolipoprotein AI, transthyretin and islet amyloid polypeptide